| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute exacerbation of asthma induced by combined therapy of programmed death-1 Blocker plus lenvatinib in a patient with advanced hepatocellular carcinoma
|
Wang, Huaiyuan
|
|
|
156 |
C |
p. 122-124
|
artikel
|
| 2 |
Comprehensive analysis of proton pump inhibitors and risk of digestive tract cancers
|
Zeng, Ruijie
|
|
|
156 |
C |
p. 190-201
|
artikel
|
| 3 |
Coronary artery disease surveillance among childhood, adolescent and young adult cancer survivors: A systematic review and recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group
|
van Dalen, Elvira C.
|
|
|
156 |
C |
p. 127-137
|
artikel
|
| 4 |
First-line treatment with chemotherapy plus cetuximab in Chinese patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: Efficacy and safety results of the randomised, phase III CHANGE-2 trial
|
Guo, Ye
|
|
|
156 |
C |
p. 35-45
|
artikel
|
| 5 |
Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor–positive metastatic breast cancer: Patient-reported outcomes in the PEARL study
|
Kahan, Zsuzsanna
|
|
|
156 |
C |
p. 70-82
|
artikel
|
| 6 |
Intention to treat versus modified intention-to-treat analysis in B-cell maturation antigen and CD19 chimeric antigen receptor trials: A systematic review and meta-analysis
|
Mohyuddin, Ghulam Rehman
|
|
|
156 |
C |
p. 164-174
|
artikel
|
| 7 |
Isolated imbalance due to bilateral vestibular failure following immune checkpoint inhibitor administration: two cases
|
Mendis, Surangi
|
|
|
156 |
C |
p. 187-189
|
artikel
|
| 8 |
Long-term efficacy update of crizotinib in patients with advanced, inoperable inflammatory myofibroblastic tumour from EORTC trial 90101 CREATE
|
Schöffski, Patrick
|
|
|
156 |
C |
p. 12-23
|
artikel
|
| 9 |
Outcomes of patients with cancer and sarcoid-like granulomatosis associated with immune checkpoint inhibitors: A case–control study
|
Cabanié, Charlotte
|
|
|
156 |
C |
p. 46-59
|
artikel
|
| 10 |
Phase III randomised trial comparing intense dose-dense chemotherapy to tailored dose-dense chemotherapy in high-risk early breast cancer (GAIN-2)
|
Möbus, Volker
|
|
|
156 |
C |
p. 138-148
|
artikel
|
| 11 |
Prognostic factor analysis and long-term results of the TAX 323 (EORTC 24971) study in unresectable head and neck cancer patients
|
Szturz, Petr
|
|
|
156 |
C |
p. 109-118
|
artikel
|
| 12 |
Prospective trial of immuno(chemo)therapy before resection, definitive chemoradiotherapy or palliative therapy in patients with locally advanced or oligometastatic non-small cell lung cancer without a primary curative option
|
Faehling, Martin
|
|
|
156 |
C |
p. 175-186
|
artikel
|
| 13 |
Real-life data for first-line combination immune-checkpoint inhibition and targeted therapy in patients with melanoma brain metastases
|
Hilbers, Marie-Luise
|
|
|
156 |
C |
p. 149-163
|
artikel
|
| 14 |
Real-world efficacy and safety of axitinib in combination with anti-programmed cell death-1 antibody for advanced mucosal melanoma
|
Tang, Bixia
|
|
|
156 |
C |
p. 83-92
|
artikel
|
| 15 |
Re: Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
|
Bayle, Arnaud
|
|
|
156 |
C |
p. 217-221
|
artikel
|
| 16 |
Resistance profiles of anaplastic lymphoma kinase tyrosine kinase inhibitors in advanced non–small-cell lung cancer: a multicenter study using targeted next-generation sequencing
|
Lin, Yen-Ting
|
|
|
156 |
C |
p. 1-11
|
artikel
|
| 17 |
Response to the letter: Re: Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
|
Jacquet, Emmanuelle
|
|
|
156 |
C |
p. 222-224
|
artikel
|
| 18 |
Safety and immunogenicity after 2 doses of the BNT162b2 COVID-19 vaccine in an early-phase oncology trial centre population
|
Malissen, Nausicaa
|
|
|
156 |
C |
p. 125-126
|
artikel
|
| 19 |
Severe acute respiratory syndrome coronavirus 2 vaccination and cancer therapy: A successful but mindful mix
|
Di Giacomo, Anna M.
|
|
|
156 |
C |
p. 119-121
|
artikel
|
| 20 |
Sex-differences in symptoms and functioning in >5000 cancer survivors: Results from the PROFILES registry
|
Oertelt-Prigione, Sabine
|
|
|
156 |
C |
p. 24-34
|
artikel
|
| 21 |
Skin cancer classification via convolutional neural networks: systematic review of studies involving human experts
|
Haggenmüller, Sarah
|
|
|
156 |
C |
p. 202-216
|
artikel
|
| 22 |
The association between effectiveness of first-line treatment and second-line treatment in gastro-oesophageal cancer
|
van Velzen, Merel J.M.
|
|
|
156 |
C |
p. 60-69
|
artikel
|
| 23 |
The evolving role of neurosurgery for central nervous system metastases in the era of personalized cancer therapy
|
Karschnia, Philipp
|
|
|
156 |
C |
p. 93-108
|
artikel
|
Tijdschrift beschrijving